144 related articles for article (PubMed ID: 33074477)
1. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A.
Xiong B; Huang J; Liu Y; Zou M; Zhao Z; Gong J; Wu X; Qiu C
Cell Oncol (Dordr); 2021 Apr; 44(2):329-343. PubMed ID: 33074477
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination.
Li T; Yan B; Ma Y; Weng J; Yang S; Zhao N; Wang X; Sun X
Cell Death Dis; 2018 Feb; 9(2):148. PubMed ID: 29396555
[TBL] [Abstract][Full Text] [Related]
3. USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma.
Lv C; Wang S; Lin L; Wang C; Zeng K; Meng Y; Sun G; Wei S; Liu Y; Zhao Y
Cell Death Dis; 2021 Aug; 12(9):803. PubMed ID: 34420039
[TBL] [Abstract][Full Text] [Related]
4. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
6. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A.
Xu BH; Li XX; Yang Y; Zhang MY; Rao HL; Wang HY; Zheng XF
Oncotarget; 2015 Aug; 6(25):20813-28. PubMed ID: 26308575
[TBL] [Abstract][Full Text] [Related]
7. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.
Kim J; Kim WJ; Liu Z; Loda M; Freeman MR
Cell Cycle; 2012 Mar; 11(6):1123-30. PubMed ID: 22370483
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA LNC473 inhibits the ubiquitination of survivin via association with USP9X and enhances cell proliferation and invasion in hepatocellular carcinoma cells.
Chen H; Yang F; Li X; Gong ZJ; Wang LW
Biochem Biophys Res Commun; 2018 May; 499(3):702-710. PubMed ID: 29605299
[TBL] [Abstract][Full Text] [Related]
10. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
11. The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth.
Li W; Cui K; Prochownik EV; Li Y
Cell Death Dis; 2018 May; 9(5):482. PubMed ID: 29706623
[TBL] [Abstract][Full Text] [Related]
12. USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma.
Gan Q; Shao J; Cao Y; Lei J; Xie P; Ge J; Hu G
Life Sci; 2020 Nov; 261():118316. PubMed ID: 32835698
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.
Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J
Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571
[TBL] [Abstract][Full Text] [Related]
14. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway.
Wang W; Shen XB; Huang DB; Jia W; Liu WB; He YF
Cell Oncol (Dordr); 2019 Dec; 42(6):769-781. PubMed ID: 31256347
[TBL] [Abstract][Full Text] [Related]
16. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
17. miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33.
Zhang CZ; Cao Y; Fu J; Yun JP; Zhang MF
Mol Oncol; 2016 Dec; 10(10):1532-1541. PubMed ID: 27693040
[TBL] [Abstract][Full Text] [Related]
18. microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression.
Heo MJ; Kim YM; Koo JH; Yang YM; An J; Lee SK; Lee SJ; Kim KM; Park JW; Kim SG
Oncotarget; 2014 May; 5(9):2792-806. PubMed ID: 24798342
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
[TBL] [Abstract][Full Text] [Related]
20. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]